Acadia Healthcare (NASDAQ:ACHC) Shares Gap Down to $81.93

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) gapped down prior to trading on Tuesday . The stock had previously closed at $81.93, but opened at $78.10. Acadia Healthcare shares last traded at $79.19, with a volume of 439,105 shares trading hands.

Analyst Ratings Changes

A number of analysts recently weighed in on ACHC shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Monday, August 19th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, May 21st. Barclays reduced their price target on shares of Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating on the stock in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Wednesday, May 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $87.44.

Acadia Healthcare Stock Performance

The company has a debt-to-equity ratio of 0.60, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a market capitalization of $7.24 billion, a P/E ratio of -585.21, a P/E/G ratio of 2.36 and a beta of 1.32. The stock’s 50 day moving average is $70.45 and its two-hundred day moving average is $72.55.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. Acadia Healthcare’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.92 earnings per share. As a group, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently bought and sold shares of ACHC. GAMMA Investing LLC bought a new stake in Acadia Healthcare in the fourth quarter valued at approximately $26,000. Blue Trust Inc. increased its stake in Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares in the last quarter. Mather Group LLC. bought a new stake in Acadia Healthcare in the first quarter valued at approximately $48,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Acadia Healthcare during the second quarter worth $59,000. Finally, nVerses Capital LLC bought a new stake in shares of Acadia Healthcare during the second quarter worth $95,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.